Markets & Finance

Two New Members for the S&P Top Ten

December 03, 2003

On Dec. 4, Standard & Poor's equity research group made changes to the S&P Top 10 portfolio -- those issues it considers to be the best candidates for capital gains over the next 6 to 12 months. S&P replaced Martek Biosciences (MATK

; recent price, $60) and Corinthian Colleges (COCO

; $55) with Landstar System (LSTR

; $36) and Hologic (HOLX

; recent price, $15).

Like all the stocks in the portfolio, Landstar and Hologic carry S&P's highest investment ranking, 5 STARS (buy). Martek and Corinthian retain their 5-STARS rankings.

Landstar provides transportation services to shippers

throughout the U.S. and, to a lesser extent, between the U.S., Canada and Mexico. S&P believes that Landstar's non-asset based, high return on investment business model makes it well positioned to benefit from an economic rebound. Our 12-month target price on Landstar is $48.